Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$510,134
-$760,514 QoQ
Shares Held
21,185
-53.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,746
of 2,821 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. PFE ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
This page
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $510,134 | 21,185 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,270,648 | 45,251 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $607,385 | 24,393 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $609,863 | 23,935 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $591,965 | 24,421 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $618,828 | 24,421 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $624,834 | 23,552 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $671,350 | 23,198 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $608,229 | 21,738 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||